This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent advancements across small molecules and biologics for cancer treatment. The research also covers innovations for the diagnosis and management of neurological disorders, apart from provide insights for the management of immunological and metabolic diseases.



The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.



The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.



Keywords: Allosteric Modulators, Neurological Diseases, Psychiatric Disorders, Biparatopic Biologics, Immune-mediated Diseases, Monoclonal Antibody, Chronic Hepatitis, Genetic Diseases, Protein Stabilization, Cancer Therapy, Oncogenes, Small Molecule Therapies, Metabolic dysfunction-associated steatohepatitis (MASH), Biomarker Diagnostic, Alzheimer’s Disease